Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...

Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...

The company has two approved medical devices in China, namely reusable insulin injection pen (GanleePen), and disposable pen ... In the future, Gan & Lee will strive for comprehensive coverage in ...

The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens ... connected insulin pens aim to empower people to better understand their diabetes management, have ...